Oct 2 |
Q4 2024 Palatin Technologies Inc Earnings Call
|
Oct 2 |
Palatin Technologies Inc (PTN) Q4 2024 Earnings Call Transcript Highlights: Strategic Moves and ...
|
Oct 1 |
Palatin Technologies, Inc. (PTN) Q4 2024 Earnings Call Transcript
|
Oct 1 |
Palatin Technologies GAAP EPS of -$0.51
|
Oct 1 |
Palatin Reports Fourth Quarter and Fiscal Year Ended 2024 Financial Results, Provides Update on Clinical Programs, Strategic Priorities, and Anticipated Milestones
|
Sep 30 |
Palatin Tech Q4 2024 Earnings Preview
|
Sep 26 |
Palatin to Report Fourth Quarter and Fiscal Year End 2024 Results
|
Sep 9 |
Palatin Provides Update on Clinical Programs, Strategic Priorities, and Anticipated Milestones
|
Aug 28 |
Palatin stock climbs 8% on Phase 3 testing update for PL9643
|
Aug 28 |
FDA Confirms Acceptability of Palatin's Remaining Phase 3 Pivotal Clinical Trials for PL9643 in Dry Eye Disease (DED)
|